Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Portal hypertension.

G Garcia-Tsao1

  • 1Yale University School of Medicine and VA Connecticut Healthcare System, New Haven, Connecticut, USA.

Current Opinion in Gastroenterology
|October 7, 2006
PubMed
Summary
This summary is machine-generated.

Cirrhosis, the end stage of chronic liver disease, causes portal hypertension and hepatic insufficiency. Understanding these and associated hemodynamic changes is key to managing complications like varices and ascites.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Invasive Fungal Infections Are Underdiagnosed in Hospitalized Patients With Decompensated Cirrhosis: An Autopsy Study.

Gastro hep advances·2022
Same author

Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.

The American journal of gastroenterology·2022
Same author

The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.

The American journal of gastroenterology·2021
Same author

Beta-blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation.

Alimentary pharmacology & therapeutics·2017
Same author

Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes.

The American journal of gastroenterology·2017
Same author

International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.

Journal of medical genetics·2009
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Cirrhosis is the advanced stage of chronic liver disease.
  • Key syndromes include portal hypertension and hepatic insufficiency.
  • Hemodynamic abnormalities like vasodilatation and hyperdynamic circulation are typical.

Purpose of the Study:

  • To review recent advances in the pathophysiology of cirrhosis complications.
  • To discuss current management strategies for cirrhosis and portal hypertension complications.

Main Methods:

  • Literature review of recent advances.
  • Synthesis of information on pathophysiology and clinical management.

Main Results:

  • Complications arise from portal hypertension, hepatic insufficiency, and hemodynamic changes.

Related Experiment Videos

  • Specific complications discussed include gastroesophageal varices, ascites, hyponatremia, hepatorenal syndrome, hepatopulmonary syndrome, and portosystemic encephalopathy.

    • Conclusions:

    • Effective management requires addressing the underlying pathophysiology of portal hypertension and hepatic insufficiency.
    • Advances in understanding hemodynamic alterations are crucial for improving patient outcomes.